Exploring the relationship between age and prognosis in glioma: rethinking current age stratification

BMC Neurol. 2022 Sep 15;22(1):350. doi: 10.1186/s12883-022-02879-9.

Abstract

Background: The age of glioma plays a unique role in prognosis. We hypothesized that age is not positively correlated with survival prognosis and explored its exact relationship.

Methods: Glioma was identified from the SEER database (between 2000 and 2018). A multivariate Cox proportional regression model and restricted cubic spline (RCS) plot were used to assess the relationship between age and prognosis.

Results: A total of 66465 patients with glioma were included. Hazard ratios (HR) for ten-year by age: 0-9 years, HR 1.06 (0.93-1.20); 10-19 years: reference; 20-29 years, HR 0.90 (0.82-1.00); 30-39 years, HR 1.14 (1.04-1.25); 40-49 years, HR 2.09 (1.91-2.28); 50-59 years, HR 3.48 (3.19-3.79); 60-69 years, HR 4.91 (4.51-5.35);70-79 years, HR 7.95 (7.29-8.66); 80-84 years, HR 12.85 (11.74-14.06). After adjusting for covariates, the prognosis was not positively correlated with age. The smooth curve of RCS revealed this non-linear relationship: HR increased to 10 years first, decreased to 23 years, reached its lowest point, and became J-shaped.

Conclusion: The relationship between age and glioma prognosis is non-linear. These results challenge the applicability of current age groupings for gliomas and advocate the consideration of individualized treatment guided by precise age.

Keywords: Age; Akaike information criterion; Brain tumors; Central nervous system; Glioblastoma multiforme; Glioma; High grade gliomas; Low grade gliomas; Restricted cubic spline; SEER.

MeSH terms

  • Brain Neoplasms* / epidemiology
  • Child
  • Child, Preschool
  • Glioma* / epidemiology
  • Humans
  • Infant
  • Infant, Newborn
  • Proportional Hazards Models